Press Releases

AlloSource Awards Dr. Matthew Provencher The Annual Dr. Steven Gitelis Inspiration Award

Centennial, Colo. — May 8, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it is awarding Dr. Matthew Provencher with its third annual Dr. Steven Gitelis Inspiration Award. The award honors a physician who understands and embraces the use of donated human tissue to help patients heal. “I am incredibly humbled to receive this award,” said Dr. Provencher. “Every day I see the healing power of donated human tissue, especially cartilage, to recreate the joint surface. Tissue donors have significantly advanced the field of orthopedics and the treatments…

AlloSource Hosts 25th Anniversary Event Featuring Columbine Survivor and Tissue Recipient Kacey Ruegsegger Johnson

Centennial, Colo. — April 25, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today celebrates 25 years of honoring donors and helping patients heal with an event featuring Columbine survivor and tissue recipient Kacey Ruegsegger Johnson. On April 20, 1999, Kacey Ruegsegger Johnson was in the library during the Columbine High School shooting. Johnson spent nearly two decades coming to terms with her experience. She recently released a memoir, Over My Shoulder: A Columbine Survivor’s Story of Resilience, Hope, and a Life Reclaimed. “Surviving the tragedy at Columbine was just…

AlloSource Announces First Patient Enrolled in ProChondrix CR Cartilage Defect Study

Centennial, Colo. — March 20, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it has enrolled the first patient in a study titled A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee. Chondral injuries impact over one million patients across the United States annually and this potentially debilitating condition can cause compromised mobility and a decline in quality of life. AlloSource’s clinical study will evaluate the effectiveness of ProChondrix CR, a fresh cryopreserved osteochondral allograft, when used for cartilage…

AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft

Centennial, Colo. — March 12, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that ProChondrix® CR now has a two-year shelf life based on the results of real-time testing. ProChondrix CR helps deliver the necessary components for articular cartilage restoration. This next generation of cartilage restoration therapy provides the live, functional cells and other biological components necessary for repair and regeneration of damaged cartilage tissues. Following cryopreservation, ProChondrix CR delivers high chondrocyte viability for up to two years (~94% avg.). The two-year shelf life helps alleviate the challenges…

AlloSource Named One Of The 2019 Training Top 125 Organizations By Training Magazine

Centennial, Colo. — February 26, 2019 — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it was named one of the 2019 Training Top 125 by Training magazine for excellence in employer-sponsored training and development programs. The Training Top 125 ranking is based on a variety of qualitative and quantitative factors, including: demonstratable Kirkpatrick Level 3 and 4 results, innovation, success factors, training strategically linked to business goals, corporate commitment to training, potential applicability of best practices companywide and to other organizations and industries, and the ingenuity of outstanding training…

AlloSource Scientists Contribute to NASA’s Jet Propulsion Laboratory Study on Antimicrobial Survivability on the International Space Station

Centennial, Colo. — December 10, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, served as a contributing science team to NASA’s Jet Propulsion Laboratory’s (JPL) scientific study on further antimicrobial survivability on the International Space Station (ISS). The science and results were highlighted in the recently published article titled “Multi-drug resistant Enterobacter bugandensis species isolated from the International Space Station and comparative genomic analyses with human pathogenic strains” in BMC Microbiology. As a follow-up to a previous study, which used molecular methods to characterize genes from ISS environmental samples, this…

AlloSource Granted Patent for Proprietary Laser Cutting Enclosure

Centennial, Colo. — November 16, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource’s method of producing a closed system that allows a laser beam to pass through and etch allograft tissue, while maintaining a sterile barrier. The proprietary method expedites processing, maximizes the use of tissue, and allows utilization of a specialized laser technology in a clean room setting. The process is used to create ProChondrix® CR, AlloSource’s fresh cryopreserved osteochondral allograft. ProChondrix CR…

AlloSource Announces Two Presentations at the North American Spine Society Annual Meeting

Centennial, Colo. — September 25, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced two presentations on the use of biologics in spinal fusion surgery at AlloSource’s booth #2031 at the North American Spine Society (NASS) Annual Meeting on Thursday, September 27. Dr. Wellington K. Hsu will present on Novel Allograft Processing Methods to Improve Osteoinductivity and Clinical Outcomes at 12:10 p.m. Dr. Hsu is a Professor of Orthopaedic Surgery and Neurological Surgery at Northwestern University Feinberg School of Medicine in Chicago, Illinois and specializes in degenerative spine surgery, cervical spine surgery,…

AlloSource Named One of the 100 Healthiest Workplaces in America by Healthiest Employers

Centennial, Colo. — September 21, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced that Healthiest Employers® named AlloSource one of the 100 Healthiest Workplaces in America. Over 1,000 organizations across the United States applied for the award, which measures employees on six essential values: vision, culture/engagement, learning, expertise, metrics and technology. Healthiest Employers’ annual “Healthiest 100 Workplaces in America” program honors leaders in corporate wellness and rewards employers that demonstrate a strategic vision for their company’s role in the overall healthcare environment. “We are honored to receive this…

AlloSource Receives Gold Level Recognition for Workplace Health From the American Heart Association

Centennial, Colo. — August 9, 2018 — AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, today announced it received Gold level recognition from the American Heart Association for promoting a workplace culture of health and wellbeing. The American Heart Association’s Workplace Health Achievement Index scores companies of all sizes on 55 best practices in seven categories: leadership, engagement, programs, policies and environment, partnerships, communications, and reporting outcomes. The AHA created the Index in collaboration with its CEO Roundtable members from some of America’s largest companies who are committed to applying evidence-based approaches…